title: Increased platelet-fibrinogen interaction in patients with hypercholesterolemia and hypertriglyceridemia.
abstract: Binding of fibrinogen to platelets washed from the blood of patients with hypercholesterolemia and hypertriglyceridemia (n = 25) and control donors (n = 12) was compared. In addition, the content of platelet glycoprotein IIb was determined by radioimmunoassay. Fibrinogen was bound in significantly higher amounts (P < 0.02) to hyperlipidaemic platelets activated by ADP than to control ones (107,112 +/- 16,371 and 45,612 +/- 6495 molecules per platelet, respectively). The mean content of GPIIb was the same in hyperlipidaemic and in control platelets (2.06 +/- 0.16 and 1.94 +/- 0.21 micrograms/10(8) platelets, respectively). The amount of fibrinogen bound to the activated hyperlipidaemic platelets showed a positive correlation with total plasma cholesterol and LDL (r = 0.45 and 0.47, respectively) whereas a negative correlation with plasma HDL was found (r = -0.50). The increased expression of fibrinogen binding sites similar to that of hyperlipidaemic platelets could be produced by preincubation of normal platelets with palmitic acid. This was evidenced by a significant increase of fibrinogen binding sites in control platelets. This suggests that either palmitoylation of the receptor or microenvironment changes in the membrane lipid bilayer may be responsible for the enhanced platelet receptor capacity to bind fibrinogen.
authors.affiliation: Department of Biophysics, Medical University Lodz, Poland.
authors.forename: Z
authors.initials: Z
authors.lastname: Pawlowska
authors.forename: M
authors.initials: M
authors.lastname: Swiatkowska
authors.forename: J
authors.initials: J
authors.lastname: Krzeslowska
authors.forename: L
authors.initials: L
authors.lastname: Pawlicki
authors.forename: C S
authors.initials: CS
authors.lastname: Cierniewski
mesh_terms: D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D000368:Aged; D001665:Binding Sites; D001792:Blood Platelets / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D015228:Hypertriglyceridemia / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D019308:Palmitic Acid; D010169:Palmitic Acids / Q000097:blood; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism
chemical_list: D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D010169:Palmitic Acids; D010980:Platelet Membrane Glycoproteins; D019308:Palmitic Acid; D000244:Adenosine Diphosphate; D005340:Fibrinogen; D002784:Cholesterol